Some derivatives of bactobolin were prepared from bactobolin by dehydration or substitution reactions through tris(dimethylamino)alkoxyphosphonium salt formation. A derivative with low toxicity, 6-deoxybactobolin, showed moderate activity against Gram-positive and Gram-negative bacteria including methicillin-resistant Staphylococcus aureus.
SYNTHESES AND ACTIVITIES
OF SOME BACTOBOLIN DERIVATIVES Yoshio Nishimura, Shinichi Kondo and Tomio Takeuchi Institute of Microbial Chemistry, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan (Received for publication October 31, 1991) Some derivatives of bactobolin were prepared from bactobolin by dehydration or substitution reactions through tris(dimethylamino)alkoxyphosphonium salt formation. A derivative with low toxicity, 6-deoxybactobolin, showed moderate activity against Gram-positive and Gram-negative bacteria including methicillin-resistant Staphylococcus aureus.
Bactobolin (1) having strong antimicrobial and antitumor activities was isolated from culture filtrates of Pseudomonassp. BMG13-A7 and the absolute structure was determined ( Fig. 1 ).1} It is structurally related to actinobolin (2) produced by Streptomyces griseoviridis var. atrofaciens.2^These antibiotics differ considerably in their biological activity including toxicity, 1 being more potent than 2.4) Their structural novelties and biological activities have stimulated interest in the total synthesis5~10) and in the chemical modification of the amino acid moiety.1 1} Furthermore, 1 demonstrated a suppressing effect on antibody production12) as well as prophylactic and therapeutic effect on autoimmune encephalomyelitis.13) On the other hand, 5-deoxybactobolin (3),14) a minor product of Pseudomonas, showed relatively low toxicity, about one fifth of the level of 1. These facts prompted us to modify the C-5 and C-6 positions of the skeleton and led to 6-ene-bactobolin (6), 6-deoxybactobolin (7), 4a,6-diene-bactobolin (9) and 6-/?-imidazoyl-6-deoxybactobolin (ll).
Synthesis
The amino group of 1 was first protected with p-methoxybenzyloxycarbonyl group15) to give 4 in 90%yield. Elimination of the 6-hydroxyl group of 4 proved troublesome until we discovered that the new dehydration process (Scheme 1) by tris(dimethylamino)alkoxyphosphonium salt16) formation in situ followed by treatment with lithium chloride at 70°C in AT,AT-dimethylformamide (DMF) gave 6-ene compound 5 in 70% yield. The 6-H and 7-H at S 6.02 (d, J= 10Hz) and 6.60 (d, /= 10Hz), respectively, in lH NMRspectrum are clearly indicative of6,7-double bond. On the other hand, the similar dehydration process was carried out at 110°C to give straightforwardly aromatized compound 8 in 70% yield. Removalof the protecting group of 5 with trifluoroacetic acid resulted in 6 (73% yield).
Reduction of 5 with palladium on carbon furnished 6-deoxy compound 7 in 75% yield. The *H NMR spectrum of7 shows protons at 1.85 (dt, J= ll and 7Hz, 6-Hax) and 2.14 (m, 6-Heq), indicative of deoxygenation at C-6. The similar deprotection of 8 yielded 9 in 81% yield. These reaction sequences are shown in Scheme2. Next, we turned our attention to the replacement of the 6-hydroxyl group with a basic substituent utilizing tris(dimethylamino)alkoxyphosphonium salt. Thus treatment of tris(dimethylamino)alkoxyphosphonium chloride of 5 with imidazole in DMF gave 6-/?-imidazoyl compound 10, which was converted upon hydrogenolysis into ll in 35% yield (Scheme 2).
Biological Activities All derivatives 6, 7, 9 and ll showed less acute intravenous toxicity in mice (tolerated at a dose of 50mg/kg) than 1 (LD50 6.25~12.5 mg/kg). However, the antimicrobial activity (Table 1 ) and cytotoxicity against mouseP388 leukemia cells and its multidrug-resistant subline, P388/ADR (Table 2) , were also decreased. Amongthem, 7 showed moderate activity against Staphylococcus aureus FDA209P and E. coli NIHJ (Table 1) as well as methicillin-resistant Staphylococcus aureus (Table 3 ). The antimicrobial activity of7 was superior to that of2 as shownin Table 3 .
Experimental General Methods
Melting points were determined with a Yanagimoto apparatus and were uncorrected. IR spectra were determined on a Hitachi Model 260-10 spectrophotometers. Optical rotations were measured with a Perkin-Elmer Model 241 polarimeter. XHNMRspectra were recorded with Jeol GX-400 and JNM-EX270 spectrometers. Chemical shifts are expressed in S values (ppm) with tetramethylsilane as an internal standard. The mass spectra were taken by a Jeol SX102. dimethylpyrimidyl-2-thiol carbonate (102.8 mg) and N,Af-diisopropylethylamine (0.27 ml), and the mixture was stirred at room temperature for 3 hours. Evaporation of the solvent gave an oil which was dissolved MICswere determined by 2-fold broth dilution method at 37°C for 17 hours in nutrient medium(S. aureus) or 0.5% peptone medium(E. coli).
in chloroform. The solution was washed with water, dried over MgSO4and filtered. Evaporation of the solvent gave an oil which was subjected to preparative thin-layer chromatography on silica gel developed with a mixture of chloroform-methanol (15 : 1) to give a colorless solid of4 (128mg, 90%). The solid was To a solution of 4 (lOOmg) in DMF(l ml) were added hexamethylphosphoric triamide (HMPT) (0.07ml) and terr-butyldimethylsilyl chloride (55.1 mg) at 0°C, and the mixture was stirred at room temperature for 4 hours. To the resulting tris(dimethylamino)alkoxyphosphonium salt was added lithium chloride (69mg), and then the mixture was stirred at 70°C overnight. Evaporation of the solvent gave an viscous solid which was taken into chloroform. Evaporation of the chloroform solution gave an oil which was subjected to preparative thin-layer chromatography on silica gel to give an oil of 5 The solution of 5 (18mg) in methanol (10ml) was stirred under an atmosphere of hydrogen gas in the presence of 10%palladium on carbon at room temperature for 3 hours. After filtration, the residue was washed with methanol. The filtrate and washings were combined and evaporated. The colorless amorphous solid of7 (9. 4a,6-Diene-2'-Ar-(/>-methoxybenzyloxycarbonyl)bactobolin (8) To a solution of4 (100mg) in dry DMF(1 ml) were added HMPT(0.07ml) and /m-butyldimethylsilyl chloride (56mg) at 0°C, and the mixture was stirred at room temperature for 3 hours. To the resulting tris(dimethylamino)alkoxyphosphonium salt was added lithium chloride (16mg), and the mixture was stirred at 1 10°C overnight. Evaporation of the solvent gave an oil which was dissolved in chloroform. The chloroform solution was washed with water, dried over MgSO4and filtered. Evaporation of the filtrate gave an oil. The oil was subjected to preparative thin-layer chromatography on silica gel developed with chloroform-methanol The solution of8 (22mg) in methanol (9ml) was stirred under an atmosphere of hydrogen gas in the presence of 10%palladium on carbon at room temperature for 3 hours. After removal of catalysts, evaporation of the solvent gave a colorless foam of9 (12.2mg 6-Deoxy-6-i5-imidazoyl-2/-A^-( /?-methoxybenzyloxycarbonyl)bactobolin (10) To a solution of 5 (200mg) in dry DMF(2ml) were added HMPT(0.14ml), terr-butyldimethylsilyl chloride (HOmg) and imidazole (50mg), and the mixture was stirred at room temperature overnight. Another portion of imidazole (50mg) was added to the mixture, and then the mixture was further stirred at room temperature overnight. Evaporation of the solvent gave an oil which was dissolved in chloroform. The chloroform solution was washed with water, dried over MgSO4and filtered. Evaporation of the filtrate gave an oil. The oil was subjected to preparative thin-layer chromatography on silica gel developed with chloroform-methanol 6-Deoxy-6-jS-imidazoylbactobolin (1 1) The solution of 10 (30mg) in methanol was stirred under an atmosphere of hydrogen gas in the presence of 5%palladium on carbon at room temperature for 6 hours. 
